PHILADELPHIA—Pancreatic duct brush cytology and fluorescence in situ hybridization during endoscopic retrograde cholangiopancreatography were shown to be safe and have moderate accuracy for diagnosing pancreatic cancer, according to the results of a retrospective cohort study of patients at a single tertiary center presented at ACG 2024.
Shuji Mitsuhashi, MBBS, a gastroenterology fellow at Mayo Clinic, in Rochester, Minn, and his co-investigators evaluated patients who had undergone